Want to see SION full AI Analyst Report?
Sionna Therapeutics, Inc. (SION) Financial Statements
Sionna Therapeutics, Inc. Financial Overview
Sionna Therapeutics, Inc.'s market cap is currently $174.97M. The company's EPS TTM is $-2.18; its P/E ratio is -1.77; Sionna Therapeutics, Inc. is estimated to report earnings on November 11, 2026, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -647.00K | $ -668.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -88.98M | $ -70.56M | $ -50.33M | $ -41.37M |
| EBITDA | $ -74.62M | $ -61.02M | $ -46.68M | $ -40.12M |
| Net Income | $ -75.27M | $ -61.69M | $ -47.26M | $ -40.24M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 235.88M | $ 147.54M | $ 38.52M | $ 82.61M |
| Total Assets | $ 325.95M | $ 185.75M | $ 51.95M | $ 87.37M |
| Total Debt | $ 8.68M | $ 9.75M | $ 10.48M | $ 0.00 |
| Net Debt | $ -49.77M | $ -28.04M | $ -28.04M | $ -54.84M |
| Total Liabilities | $ 19.12M | $ 349.46M | $ 166.83M | $ 157.29M |
| Stockholders' Equity | $ 306.83M | $ -163.71M | $ -114.88M | $ -69.92M |
| Cash Flow | ||||
| Free Cash Flow | $ -66.67M | $ -52.81M | $ -44.81M | $ -37.94M |
| Operating Cash Flow | $ -66.30M | $ -52.79M | $ -43.70M | $ -36.07M |
| Investing Cash Flow | $ -118.75M | $ -126.91M | $ 27.35M | $ -29.26M |
| Financing Cash Flow | $ 205.71M | $ 178.97M | $ 31.00K | $ 110.86M |
Currency in USD
